Monogram [MGRM] vs Boston Scientific [BSX] Detailed Stock Comparison

Monogram Technologies Inc.

NASDAQ
Loading...

Boston Scientific Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Monogram Technologies Inc. wins in 4 metrics, Boston Scientific Corporation wins in 12 metrics, with 0 ties. Boston Scientific Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Monogram Technologies Inc. Boston Scientific Corporation Better
P/E Ratio (TTM) -13.04 27.49 Boston Scientific Corporation
Price-to-Book Ratio 25.10 4.02 Boston Scientific Corporation
Debt-to-Equity Ratio 3.44 48.92 Monogram Technologies Inc.
PEG Ratio -0.29 0.29 Boston Scientific Corporation
EV/EBITDA -16.52 19.85 Boston Scientific Corporation
Profit Margin (TTM) 0.00% 17.29% Boston Scientific Corporation
Operating Margin (TTM) 0.00% 21.55% Boston Scientific Corporation
EBITDA Margin (TTM) N/A 21.55% N/A
Return on Equity -228.82% 11.84% Boston Scientific Corporation
Return on Assets (TTM) -72.90% 6.64% Boston Scientific Corporation
Free Cash Flow (TTM) $-14.05M $3.40B Boston Scientific Corporation
1-Year Return 157.51% -52.97% Monogram Technologies Inc.
Price-to-Sales Ratio (TTM) N/A 4.74 N/A
Enterprise Value $231.23M $107.72B Boston Scientific Corporation
EV/Revenue Ratio N/A 5.23 N/A
Revenue per Share (TTM) $0 $14 Boston Scientific Corporation
Earnings per Share (Diluted) $-0.54 $2.39 Boston Scientific Corporation
Beta (Stock Volatility) 0.69 0.78 Monogram Technologies Inc.
Short % of Float 0.49% 1.58% Monogram Technologies Inc.

Monogram Technologies Inc. vs Boston Scientific Corporation Stock Performance Analysis

Loading Price Chart...

MGRM
BSX

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Monogram Technologies Inc.0.00%1.69%4.35%81.82%151.05%138.10%
Boston Scientific Corporation-0.32%-3.98%-11.24%-33.00%-49.28%-50.63%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Monogram Technologies Inc.157.51%-55.56%-55.56%-55.56%-55.56%-55.56%
Boston Scientific Corporation-52.97%-13.64%9.04%108.58%590.87%133.50%

Performance & Financial Health Analysis: Monogram Technologies Inc. vs Boston Scientific Corporation

MetricMGRMBSX
Market Information
Market Cap i$244.21M$97.63B
Market Cap CategoryMicro capLarge cap
10 Day Avg. Volume i262,12018,916,072
90 Day Avg. Volume i155,39316,730,711
Last Close$6.00$46.76
52 Week Range$1.92 - $6.13$45.99 - $109.50
% from 52W High-2.12%-57.30%
All-Time High$48.99 (May 15, 2023)$109.50 (Sep 09, 2025)
% from All-Time High-87.75%-57.30%
Growth Metrics
Quarterly Revenue GrowthN/A0.12%
Quarterly Earnings GrowthN/A0.99%
Financial Health
Profit Margin (TTM) i0.00%0.17%
Operating Margin (TTM) i0.00%0.22%
Return on Equity (TTM) i-2.29%0.12%
Debt to Equity (MRQ) i3.4448.92
Cash & Liquidity
Book Value per Share (MRQ)$0.24$16.34
Cash per Share (MRQ)$0.32$1.32
Operating Cash Flow (TTM) i$-12,101,000$4.50B
Levered Free Cash Flow (TTM) i$-3,877,400$10.53B
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Monogram Technologies Inc. vs Boston Scientific Corporation

MetricMGRM (Oct 22, 2025)BSX (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-13.0427.49
Forward P/E i-12.5017.29
PEG Ratio i-0.290.29
Price to Sales (TTM) iN/A4.74
Price to Book (MRQ) i25.104.02
Market Capitalization
Market Capitalization i$244.21M$97.63B
Enterprise Value i$231.23M$107.72B
Enterprise Value Metrics
Enterprise to Revenue iN/A5.23
Enterprise to EBITDA i-16.5219.85
Risk & Other Metrics
Beta i0.690.78
Book Value per Share (MRQ) i$0.24$16.34

Financial Statements Comparison: Monogram Technologies Inc. vs Boston Scientific Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricMGRM (2024)BSX (2025)
Revenue/Sales i020.07B
Cost of Goods Sold iN/A6.22B
COGS % of Revenue i-31.0%
Gross Profit iN/A13.85B
Gross Margin i-69.0%
Research & Development i8.79M2.05B
Operating Income (EBIT) i-15.31M3.97B
Operating Margin i-19.8%
EBITDA i-14.88M5.33B
EBITDA Margin i-26.6%
Pre-Tax Income i-16.33M3.39B
Pre-Tax Income % of Revenue i-16.9%
Income Tax i0493.00M
Income Tax % of Revenue i-2.5%
Net Income (Profit) i-16.33M2.89B
Profit Margin i-14.4%

Balance Sheet & Liquidity Metrics

MetricMGRM (2024)BSX (2025)
Cash & Equivalents i15.66M1.97B
Total Current Assets i16.28M8.79B
Total Current Assets % of Revenue i-43.8%
Total Current Liabilities i1.54M5.44B
Total Current Liabilities % of Revenue i-27.1%
Long-Term Debt i226,00011.14B
Long-Term Debt % of Revenue i-55.5%
Total Shareholders Equity i14.50M24.47B
Retained Earnings i-67.99M5.57B
Retained Earnings % of Revenue i-27.8%
Property, Plant & Equipment i1.32M0

Cash Flow Statement Comparison

MetricMGRM (2024)BSX (2025)
Operating Cash Flow i-14.10M4.50B
Operating Cash Flow % of Revenue i-22.4%
Capital Expenditures i-84,000-876.00M
Free Cash Flow i-14.05M3.40B
FCF Margin i-17.0%
Debt Repayment iN/A-2.05B
Common Stock Repurchase i-200,000N/A

Short Interest & Institutional Ownership Analysis

MetricMGRMBSX
Shares Short i161,43123.53M
Short Ratio i1.661.59
Short % of Float i0.49%1.58%
Shares Outstanding i36.09M1.49B
Float Shares i30.58M1.48B
% Held by Insiders i54.55%0.21%
% Held by Institutions i4.97%95.16%
% Held by Public i40.48%4.63%

Dividend Analysis & Yield Comparison: Monogram Technologies Inc. vs Boston Scientific Corporation

MetricMGRMBSX
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A